Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 5 Recurrence 3 Neoplasms 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Carcinoma, Non-Small-Cell Lung 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Ovarian Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Cytokine Release Syndrome 1 Craniopharyngioma 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Advanced Liver Cancers 1

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Liver Cancers × tocilizumab × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡